Pilot and Translational Study of Dasatinib (NSC#732517) Paclitaxel and Carboplatin in Women With Advanced Stage and Recurrent Endometrial Cancer
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Dasatinib (Primary) ; Carboplatin; Paclitaxel
- Indications Endometrial cancer
- Focus Pharmacogenomic; Therapeutic Use
- 04 Apr 2018 Status changed from active, no longer recruiting to completed.
- 10 Jul 2017 Planned End Date changed from 1 Jul 2015 to 1 Dec 2017.
- 22 Dec 2015 Planned End Date changed from 1 Jun 2014 to 1 Jul 2015, according to ClinicalTrials.gov record.